InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Arkowitz David, 首席财务官. Director active across 5 companies, notably Flexion Therapeutics Inc. Cumulatively, 11 reports have been published. Split: 1 buy · 2 sells. Total volume traded: €67k. Activity tracked since 10 May 2021. The latest transaction was disclosed on 23 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
David Arkowitz is the Chief Financial Officer of Flexion Therapeutics Inc. He oversees the financial management of the company, including planning and financial reporting.